QTRX
Quanterix Corp
NASDAQ: QTRX · HEALTHCARE · MEDICAL DEVICES
$3.13
+2.62% today
Updated 2026-04-30
Market cap
$157.20M
P/E ratio
—
P/S ratio
1.13x
EPS (TTM)
$-2.51
Dividend yield
—
52W range
$3 – $9
Volume
0.9M
Quanterix Corp (QTRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.52M | $-17.74M | $-22.11M | $-28.72M | $-26.19M | $-23.36M | $-47.91M | $-48.27M | $-18.90M | $-35.16M | $-77.24M |
| Capital expenditures | $597000.00 | $526000.00 | $1.13M | $1.52M | $10.85M | $3.93M | $13.62M | $11.73M | $3.79M | $3.37M | $2.61M |
| Depreciation | $425000.00 | $444000.00 | $482000.00 | $1.35M | $3.01M | $4.31M | $4.85M | $5.35M | $8.38M | $8.36M | — |
| Stock-based comp | $1.10M | $928000.00 | $2.17M | $4.88M | $6.39M | $10.10M | $15.97M | $15.44M | $16.76M | $19.99M | $20.72M |
| Free cash flow | $-13.11M | $-18.27M | $-23.24M | $-30.24M | $-37.03M | $-27.30M | $-61.52M | $-60.00M | $-22.69M | $-38.53M | $-79.85M |
| Investing cash flow | $-554000.00 | $-826000.00 | $-1.13M | $-5.45M | $-25.38M | $-626000.00 | $-6.34M | $-11.21M | $-148.40M | $-82.27M | — |
| Financing cash flow | $11.70M | $45.92M | $73.25M | $-78000.00 | $116.20M | $96.24M | $270.80M | $2.31M | $2.69M | $456000.00 | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-34.25M | $64.63M | $72.25M | $216.55M | $-57.17M | — | — | — |